Odyssey Health (ODYY) Long-Term Investments (2017 - 2025)
Odyssey Health's (ODYY) quarterly Long-Term Investments came in at $97149.0 in Q2 2025, down 99.28% year-on-year from $13.4 million in Q2 2024, and down 38.71% quarter-over-quarter from $158505.0 in Q1 2025.
Odyssey Health (ODYY) Long-Term Investments (2017 - 2025) Analysis & Trends
Odyssey Health's Long-Term Investments history runs 3 years deep, the most recent figure standing at $97149.0 for Q2 2025.
- On a quarterly basis, Long-Term Investments fell 99.28% year-over-year to $97149.0 in Q2 2025; TTM through Apr 2025 was $97149.0, a 99.28% decrease from a year earlier, with the FY2024 full-year figure at $529203.0, changed N/A from the prior year.
- Long-Term Investments slipped to $97149.0 in Q2 2025 per ODYY's latest filing, from $158505.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $13.8 million in Q1 2024 and bottomed at $97149.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2017 | 130,395.00 |
| Jul 31, 2017 | 107,157.00 |